PFE.MX's stock price, like any stock, is influenced by a multitude of factors. Company Performance: Pfizer's financial health, including revenue, earnings, and profitability, directly impacts investor confidence.

Drug Pipeline: Success or failure in clinical trials and regulatory approvals for new drugs significantly affects future growth prospects.

Market Conditions: General economic trends, interest rates, and inflation can influence overall market sentiment and investment decisions.

Competitor Actions: Developments from rival pharmaceutical companies, such as new drug launches or mergers, can impact Pfizer's market share and valuation.

Regulatory Changes: Government regulations regarding drug pricing, healthcare policy, and intellectual property can create uncertainty and affect profitability.

Investor Sentiment: Overall investor confidence in the pharmaceutical sector and in Pfizer's management team plays a crucial role.

Global Health Events: Pandemics or outbreaks can create both opportunities and challenges for vaccine and drug manufacturers like Pfizer.

Currency Fluctuations: Exchange rates between the Mexican Peso and other currencies can impact revenue generated from international sales.

Dividend Policy: Changes to Pfizer's dividend payout ratio or yield can attract or deter investors depending on their investment goals.

Economic Outlook: The economic health of Mexico specifically can affect the demand for pharmaceuticals within the Mexican market, which is reflected on the PFE.MX.